412 related articles for article (PubMed ID: 29803351)
1. Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies.
Corona G; Rastrelli G; Di Pasquale G; Sforza A; Mannucci E; Maggi M
J Sex Med; 2018 Jun; 15(6):820-838. PubMed ID: 29803351
[TBL] [Abstract][Full Text] [Related]
2. Testosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased Risk.
Khera M; Miner M; Jaffe J; Pastuszak AW
J Sex Med; 2021 Jan; 18(1):83-98. PubMed ID: 33317996
[TBL] [Abstract][Full Text] [Related]
3. Endogenous Testosterone Levels and Cardiovascular Risk: Meta-Analysis of Observational Studies.
Corona G; Rastrelli G; Di Pasquale G; Sforza A; Mannucci E; Maggi M
J Sex Med; 2018 Sep; 15(9):1260-1271. PubMed ID: 30145097
[TBL] [Abstract][Full Text] [Related]
4. [Testosterone replacement therapy and cardiovascular risk].
Corona G; Dicuio M; Rastrelli G; Sforza A; Maggi M
G Ital Cardiol (Rome); 2017 Nov; 18(11):745-753. PubMed ID: 29105668
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular impact of testosterone therapy for hypogonadism.
Rastrelli G; Dicuio M; Reismann Y; Sforza A; Maggi M; Corona G
Expert Rev Cardiovasc Ther; 2018 Sep; 16(9):617-625. PubMed ID: 30099911
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Morbidity and Mortality in Men - Findings From a Meta-analysis on the Time-related Measure of Risk of Exogenous Testosterone.
Fallara G; Pozzi E; Belladelli F; Corsini C; Boeri L; Capogrosso P; Montorsi F; Salonia A
J Sex Med; 2022 Aug; 19(8):1243-1254. PubMed ID: 35753891
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.
Hackett G
Sex Med Rev; 2019 Jul; 7(3):476-490. PubMed ID: 30803918
[TBL] [Abstract][Full Text] [Related]
8. Testosterone Therapy: What We Have Learned From Trials.
Corona G; Torres LO; Maggi M
J Sex Med; 2020 Mar; 17(3):447-460. PubMed ID: 31928918
[TBL] [Abstract][Full Text] [Related]
9. Alternatives to Testosterone Therapy: A Review.
Lo EM; Rodriguez KM; Pastuszak AW; Khera M
Sex Med Rev; 2018 Jan; 6(1):106-113. PubMed ID: 29174957
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular safety of testosterone replacement therapy in men: an updated systematic review and meta-analysis.
Corona G; Rastrelli G; Sparano C; Carinci V; Casella G; Vignozzi L; Sforza A; Maggi M
Expert Opin Drug Saf; 2024 May; 23(5):565-579. PubMed ID: 38553429
[TBL] [Abstract][Full Text] [Related]
11. Testosterone treatment and cardiovascular and venous thromboembolism risk: what is 'new'?
Corona G; Dicuio M; Rastrelli G; Maseroli E; Lotti F; Sforza A; Maggi M
J Investig Med; 2017 Aug; 65(6):964-973. PubMed ID: 28495861
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis.
Corona G; Maseroli E; Rastrelli G; Isidori AM; Sforza A; Mannucci E; Maggi M
Expert Opin Drug Saf; 2014 Oct; 13(10):1327-51. PubMed ID: 25139126
[TBL] [Abstract][Full Text] [Related]
13. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.
Haddad RM; Kennedy CC; Caples SM; Tracz MJ; Boloña ER; Sideras K; Uraga MV; Erwin PJ; Montori VM
Mayo Clin Proc; 2007 Jan; 82(1):29-39. PubMed ID: 17285783
[TBL] [Abstract][Full Text] [Related]
14. An update on heart disease risk associated with testosterone boosting medications.
Corona G; Rastrelli G; Guaraldi F; Tortorici G; Reismann Y; Sforza A; Maggi M
Expert Opin Drug Saf; 2019 Apr; 18(4):321-332. PubMed ID: 30998433
[TBL] [Abstract][Full Text] [Related]
15. Erythrocytosis Following Testosterone Therapy.
Ohlander SJ; Varghese B; Pastuszak AW
Sex Med Rev; 2018 Jan; 6(1):77-85. PubMed ID: 28526632
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setting Comparing Treated and Untreated (Control) Groups.
Traish AM; Haider A; Haider KS; Doros G; Saad F
J Cardiovasc Pharmacol Ther; 2017 Sep; 22(5):414-433. PubMed ID: 28421834
[TBL] [Abstract][Full Text] [Related]
17. Testosterone deficiency and cardiovascular mortality.
Morgentaler A
Asian J Androl; 2015; 17(1):26-31. PubMed ID: 25432501
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.
Jones TH; Kelly DM
Asian J Androl; 2018; 20(2):120-130. PubMed ID: 29442075
[TBL] [Abstract][Full Text] [Related]
19. Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study.
Haider A; Yassin A; Haider KS; Doros G; Saad F; Rosano GM
Vasc Health Risk Manag; 2016; 12():251-61. PubMed ID: 27366080
[TBL] [Abstract][Full Text] [Related]
20. The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk.
Miner M; Morgentaler A; Khera M; Traish AM
Clin Endocrinol (Oxf); 2018 Jul; 89(1):3-10. PubMed ID: 29486065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
